Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models. Dai H, Zhu C, Huai Q, Xu W, et al. J Hepatol 2024;80:913-927.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dai H, Zhu C, Huai Q, Xu W, et al. Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models. J Hepatol 2024;80:913-927.
PMID: 38340812